Shelton Capital Management Boston Scientific Corp Transaction History

Shelton Capital Management

$3.85 Billion
Q3 2024

A detailed history of Shelton Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Shelton Capital Management holds 183,875 shares of BSX stock, worth $16.5 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

183,875

Previous 127,964 43.69%

Holding current value

$16.5 Million

Previous $9.85 Million 56.36%

% of portfolio

0.4%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $4.08 Million - $4.7 Million	55,911 Added 43.69%	183,875 $15.4 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $1.68 Million - $1.94 Million	24,905 Added 24.17%	127,964 $9.85 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $5.11 Million - $6.09 Million	88,700 Added 617.73%	103,059 $7.06 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $9.88 Million - $11.7 Million	-203,077 Reduced 93.4%	14,359 $830,000
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $1.93 Million - $2.11 Million	38,500 Added 21.52%	217,436 $11.5 Million
Q2 2023 Aug 10, 2023	BUY	$49.72 - $54.64 $5.76 Million - $6.33 Million	115,900 Added 183.86%	178,936 $9.68 Million
Q1 2023 May 11, 2023	BUY	$45.09 - $50.03 $2.43 Million - $2.7 Million	54,000 Added 597.61%	63,036 $3.15 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $11.7 Million - $14 Million	-296,400 Reduced 97.04%	9,036 $418,000
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $1.2 Million - $3.57 Million	32,600 Added 11.95%	305,436 $11.8 Million
Q2 2022 Aug 11, 2022	BUY	$35.24 - $47.1 $602,604 - $805,410	17,100 Added 6.69%	272,836 $10.2 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $560,330 - $617,870	-13,700 Reduced 5.08%	255,736 $11.3 Million
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $3.35 Million - $3.94 Million	87,884 Added 48.41%	269,436 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $2.82 Million - $3.14 Million	68,500 Added 60.59%	181,552 $7.88 Million
Q2 2021 Aug 12, 2021	BUY	$38.58 - $44.24 $1.88 Million - $2.15 Million	48,700 Added 75.68%	113,052 $4.83 Million
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $1.92 Million - $2.16 Million	54,515 Added 554.18%	64,352 $2.49 Million
Q4 2019 Feb 11, 2020	SELL	$37.87 - $45.37 $63,962 - $76,629	-1,689 Reduced 14.65%	9,837 $445,000
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $386,802 - $476,218	11,080 Added 2484.3%	11,526 $495,000
Q1 2019 May 10, 2019	SELL	$32.91 - $40.75 $364,642 - $451,510	-11,080 Reduced 96.13%	446 $11.6 Million
Q1 2017 Nov 28, 2017	SELL	N/A	-300 Reduced 2.54%	11,526 $287,000
Q4 2016 Nov 29, 2017	SELL	N/A	-900 Reduced 7.07%	11,826 $256,000
Q3 2016 Dec 06, 2017	BUY	N/A	900 Added 7.61%	12,726 $303,000
Q3 2016 Dec 04, 2017	BUY	N/A	11,826	11,826 $256,000

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Account

Shelton Capital Management Boston Scientific Corp Transaction History